Metabolomics: Technologies and Applications - A Global Market Overview

News provided by

Research and Markets

04 Dec, 2014, 16:26 GMT

DUBLIN, Dec. 02, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Metabolomics: Technologies and Applications - A Global Market Overview" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Large pharma companies have yet to take on a full-blown adoption of metabolomic technologies, when compared to proteomic and genomic research. This is because of the lingering uncertainties as to the advantages offered by metabolomics that have been the outcome of failed proteomics and genomics research programs. Through some recent accomplishments have been able to dispel some of these doubts, wider adoption and acceptance of metabolomics would necessitate additional landmark successes in R&D.

In all probability, the future of metabolomics is slated to hinge on discovering biomarkers for determining the presence of disease in an individual biological system. As biological inputs, such as blood glucose levels for diabetes or high cholesterol levels for heart disease, are already being utilized for confirming disease presence, metabolomics can derive benefit from an understanding of biochemical pathways. The existing focus of metabolomics has been on 20-100 different metabolites and while this constitutes a very small proportion compared to other fields of omics, this discipline has been making robust progress in discovering biomarkers.

Metabolomics analytical techniques analyzed in this report includes Separation Techniques - Capillary Electrophoresis, Gas Chromatography, High Performance Liquid Chromatography (HPLC) and Ultra Performance Liquid Chromatography (UPLC); and Detection Techniques - Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy and Surface-Based Mass Analysis. The report also analyzes the metabolomics applications comprising Biomarker Discovery, Drug Discovery, Nutrigenomics, Toxicology Testing and Other Applications. Metabolomics therapeutic areas explored in this study includes Cardiology, Neurology, Oncology and Other Diseases.

The global markets for the above mentioned metabolomic analytical techniques, end-use applications and the therapeutic areas are analyzed in terms of value in USD. Metabolomic separation techniques account for over half of the global metabolomics market estimated at US$395.2 million in 2014 while detection techniques shares with US$308.8 million. Biomarker discovery projected to be the fastest growing end use sector with 2014-2020 CAGR of 25.2% and also estimated the largest market for metabolomics in 2014 with US$252.8 million closely followed by drug discovery with US$211.1 million.

The report reviews, analyses and projects the metabolomics technologies, applications and therapeutic areas market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 9 independent countries across North America - The United States and Canada; Europe - France, Germany, Italy and the United Kingdom; Asia-Pacific - China, India and Japan.


Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

2. APPLICATION ANALYSIS OF METABOLOMICS

3. KEY MARKET TRENDS

4. KEY GLOBAL PLAYERS

5. KEY BUSINESS TRENDS

6. GLOBAL MARKET OVERVIEW

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA

2. EUROPE

3. ASIA-PACIFIC

4. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

2. EUROPE

3. ASIA-PACIFIC

PART D: ANNEXURE

1. RESEARCH METHODOLOGY
2. FEEDBACK


Companies Mentioned:

  • Agilent Technologies
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • GERSTEL GmbH & Co. KG
  • Genedata AG
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolomic Discoveries GmbH
  • Metabolomic Technologies Inc.
  • Metabolomx
  • Metabolon, Inc.
  • Phenomenome Discoveries Inc.
  • Shimadzu Corporation
  • Sigma-Aldrich Co. LLC.
  • Stemina Biomarker Discovery, Inc.
  • Thermo Fisher Scientific Inc
  • Waters Corporation

For more information visit http://www.researchandmarkets.com/research/v5p22t/metabolomics

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com